Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine for Subarachnoid Haemorrhage (Phase II RCT)
ChiCTR2500110134Phase 2Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Taurine intervention arm with Placebo arm (2 arms). Primary endpoints: S100B (primary), Malondialdehyde (MDA) (primary) and 5 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
taurine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ChiCTR2500110134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110134.